je.st
news
Alchemia drug sale boosts shares
2015-09-25 09:44:56| Biotech - Topix.net
Shares in Alchemia have nearly doubled in price after the drug developer agreed to sell its major asset, the generic anti-coagulant fondaparinux sodium. Shares in Alchemia were up 3.3 cents, or 94.29 per cent, at 6.8 cents at 1135 AEST.
Tags: sale
drug
shares
boosts
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||